It has been recently proposed that MASLD was linked to elevated plasma Aβ levels in rats and humans, through compromised LRP‐1‐mediated peripheral Aβ clearance, while the carrier of the LRP‐1 rs1799986 T polymorphism showed marked reduction in Aβ levels.45 The gene discussed is LRP1; the disease is metabolic dysfunction-associated steatotic liver disease.